2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Leukoplakia: new trials by email Literature Review of Leukoplakia trials Research Report on Leukoplakia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pioglitazone for Oral Premalignant Lesions Pioglitazone hydrochloride, placebo, laboratory biomarker analysis - Oral Leukoplakia | Phase 2 | Terminated | National Cancer Institute (NCI) | 52 | 2010-02-01 | 2016-04-06 |
| A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia Lozenge Intake - Oral Leukoplakia | Phase 2 | Terminated | University of Medicine and Dentistry of New Jersey | 8 | 2003-09-01 | 2009-12-11 |
Head and Neck Neoplasms (2) · Mouth Diseases (2) · Mouth Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Precancerous Conditions (2) · Stomatognathic Diseases (2)
Pioglitazone (1)
National Cancer Institute (NCI) (1) · University of Medicine and Dentistry of New Jersey (1)
United States (2) · Canada (1) · Italy (1)
Powel H. Brown (1) · Susan Goodin, PharmD (1)
N01CN35153 (1), N01CN35159 (1), P30CA016672 (1)